The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial—Revisited
Abstract
OBJECTIVE— The Diabetes Control and Complications Trial (Diabetes 44:968–983, 1995) presented statistical models suggesting that subjects with similar A1C levels had a higher risk of retinopathy progression in the conventional treatment group than in the intensive treatment group. That analysis has been cited to support the hypothesis that specific patterns of glucose variation, in particular postprandial hyperglycemia, contribute uniquely to an increased risk of microvascular complications above and beyond that explained by the A1C level. RESEARCH DESIGN AND METHODS— We performed statistical evaluations of these models and additional analyses to assess whether the original analyses were flawed. RESULTS— Statistically, we show that the original results are an artifact of the assumptions of the statistical model used. Additional analyses show that virtually all (96%) of the beneficial effect of intensive versus conventional therapy on progression of retinopathy is explained by the reductions in the mean A1C levels, similarly for other outcomes. Furthermore, subjects within the intensive and conventional treatment groups with similar A1C levels over time have similar risks of retinopathy progression, especially after adjusting for factors in which they differ. CONCLUSIONS— A1C explains virtually all of the difference in risk of complications between the intensive and conventional groups, and a given A1C level has similar effects within the two treatment groups. While other components of hyperglycemia, such as glucose variation, may contribute to the risk of complications, such factors can only explain a small part of the differences in risk between intensive and conventional therapy over time.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
(2001) · Statistics for Psychologists · doi:10.4324/9781410605542-11 · Cited by 6,877
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Fundus Photographic Risk Factors for Progression of Diabetic Retinopathy
(1991) · Ophthalmology · doi:10.1016/s0161-6420(13)38014-2 · Cited by 814
Diabetes Control and Complications Trial (DCCT) Research Group (1996) · Diabetes · doi:10.2337/diab.45.10.1289 · Cited by 597
Glycemic Variability: A Hemoglobin A1c–Independent Risk Factor for Diabetic Complications
Brownlee, M., & Hirsch, I. B. (2006) · JAMA · doi:10.1001/jama.295.14.1707 · Cited by 482
The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes
Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2006) · Diabetes Care · doi:10.2337/dc06-0293 · Cited by 377
Biostatistical methods : the assessment of relative risks
Lachin, J. M. (2000) · Cited by 272
Self-citation
Cited by
Items 301–400 of 555
Burckhardt, M., Auzanneau, M., Rosenbauer, J., Binder, E. B., Weiskorn, J., Hess, M., Klinkert, C., Mirza, J., Zehnder, L.-S., Wenzel, S., et al. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241288870 · Cited by 10
“29 A recent study examining the association of TTR and TIR with the presence of microvascular complications and cerebrovascular insults in adults with type 1 diabetes found an inverse association with the presence of microvascular complications and cerebrovascular accidents.”
Tomić, M., Vrabec, R., Bulum, T., & Ljubić, S. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109814 · Cited by 10
Moheghi, A., Mougahi, S. M. H. N., Amini, A., Mostafavinia, A., Rezaei, F., Tadi, F. B., Chien, S., & Bayat, M. (2023) · Journal of lasers in medical sciences · doi:10.34172/jlms.2023.45 · Cited by 10
Lockhart, C., McCann, A. J., Pinnock, R. A., Hamilton, P., Harbinson, M., & McVeigh, G. E. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00372.2014 · Cited by 10
Motherhood, Apple Pie, Hemoglobin A1C, and the DCCT
Trence, D., & Hirsch, I. B. (2012) · Endocrine Practice · doi:10.4158/ep11359.ra · Cited by 12
Yoo, K.-H., Shin, D. W., Cho, M. H., Kim, S.-H., Bahk, H. J., Kim, S.-H., Jeong, S., Yun, J., Park, J., Kim, H.-S., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.06.008 · Cited by 10
Pan, H., Lee, C., Chou, K.-M., Lu, S.-C., & Sun, C. (2017) · Medicine · doi:10.1097/md.0000000000008053 · Cited by 10
“5%.([20]) The follow-up examinations were conducted after 1 year, and the physical parameters, blood and urine laboratory test results, along with the survey, were recorded again.”
BackgroundControversies for Glucose Control Targets in Type 2 Diabetes: Exposing the Common Ground
Home, P. D. (2019) · Diabetes Care · doi:10.2337/dci19-0002 · Cited by 13
Depression and Severity of Glaucoma Among Older Adults in Urban and Suburban Areas
Tharmathurai, S., Muhammad-Ikmal, M. K., Razak, A. A., Che-Hamzah, J., Yaakub, A., Fazilawati, Q., & Liza-Sharmini, A. T. (2021) · Journal of Glaucoma · doi:10.1097/ijg.0000000000001830 · Cited by 12
Sarray, S., Lamine, L. B., Dallel, M., Jairajpuri, D. S., Turki, A., Sellami, N., Ezzidi, I., Abdelhadi, M. A., Brock, R. E., Ghorbel, M., et al. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108182 · Cited by 11
Fischer, T. (2015) · Orvosi Hetilap · doi:10.1556/oh.2015.30017 · Cited by 12
Benhamou, P., Somers, F., Lablanche, S., Debaty, I., Borel, A., Nasse, L., Stanke‐Labesque, F., Faure, P., Boizel, R., & Halimi, S. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.01.004 · Cited by 10
Perreault, L., Færch, K., & Gregg, E. W. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0899-7 · Cited by 12
Dallo, F. J., Ruterbusch, J. J., McCullough, J. R., Sreedhar, S., Schwartz, K., & Mulhem, E. (2018) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-018-0777-7 · Cited by 9
Diabetische Retinopathie und Makulopathie
Lemmen, K. D., & Martin, S. (2008) · Der Diabetologe · doi:10.1007/s11428-008-0220-0 · Cited by 9
Tadi, F. B., Mougahi, S. M. H. N., Mostafavinia, A., Moheghi, A., Amini, A., Rezaei, F., Chien, S., & Bayat, M. (2022) · Lasers in Medical Science · doi:10.1007/s10103-022-03630-z · Cited by 9
“As a result of improper control, DM may lead to chronic complications [4].”
BackgroundFilipov, A., Fuchshuber, H., Kraus, J., Ebert, A., Sandikci, V., & Alonso, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11061625 · Cited by 9
Jensen, T. M., Vistisen, D., Fleming, T. H., Nawroth, P. P., Jørgensen, M. E., Lauritzen, T., Sandbæk, A., & Witte, D. R. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0739-7 · Cited by 9
“These mechanisms may help explain why some diabetic patients go on to develop complications despite good glycaemic control [14].”
Modern clinical management helps reducing the impact of type 1 diabetes in children
Scaramuzza, A. E., & Zuccotti, G. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.03.001 · Cited by 9
Lou, Q., Yuan, X., Hao, S., Miller, J. D., Yan, J., Zuo, P., Li, J., Yang, L., & Li, H. (2020) · Journal of Diabetes Research · doi:10.1155/2020/2532171 · Cited by 11
“Long-term data from UKPDS, DCCT, VADT, and other large studies have confirmed that controlling HbA1c to the ideal level can significantly reduce the occurrence of microvascular complications but cannot necessarily effectively reduce the incidence of cardiovascular and cerebrovascular events in patients with diabetes […”
BackgroundIFI44L and C1QTNF5 as promising biomarkers of proliferative diabetic retinopathy
Shang, M., Zhang, Y., & Zhang, T. (2022) · Medicine · doi:10.1097/md.0000000000031961 · Cited by 9
“[6] These may be closely associated with the influence of genetic factors.[7] With the rapid development of genomics, many genes have been found to be related to PDR, such as vascular endothelial growth factor (VEGF),[8] hypoxia-inducible factor 1-α (HIF1A),[9] erythropoietin (EPO),[10] receptor for advanced glycation…”
BackgroundNathan, D. M. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.438 · Cited by 8
Self-citationSämann, A., & Wolf, G. (2012) · Der Internist · doi:10.1007/s00108-012-3129-z · Cited by 9
“Eine zu aggressive Absenkung des HbA1c-Wertes führte allerdings in der ACCORD-Studie zu einem Anstieg der Mortalität [27].”
BackgroundInfluentialAddressing unmet needs for chronic kidney disease treatment in type 1 diabetes: A review
Tuttle, K. R., Ji, L., Mathieu, C., & Rosen, J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70180 · Cited by 8
“17 In addition, reductions in HbA1 C accounted for most of the improvements in CKD outcomes in the DCCT. 18 Together, these results emphasise the importance of controlling hyperglycemia in T1D to prevent onset and progression of CKD.”
Mosa, A. S. M., Thongmotai, C., Islam, H., Paul, T., Hossain, K. S. M. T., & Mandhadi, V. (2021) · Journal of Business Analytics · doi:10.1080/2573234x.2021.1979901 · Cited by 11
“Extensive prospective clinical studies show a strong relationship between glycaemia and diabetic microvascular complications in type 1 and type 2 (Lachin et al., 2008).”
BackgroundHealth literacy and diabetic retinopathy
Breder, J. D. S. C., Breder, I. S. S., Barreto, J., Fernandes, V., Zanchetta, F. C., Oliveira, B., Chaves, F. R. P., Sposito, A. C., & Lima, M. H. M. (2024) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2023e13066 · Cited by 8
“Our study took this investigation one step further by performing mediation analyses based on well-established risk factors for the development of DR, i.e., high levels of HbA1c, LDL-C, and BP (9).”
BackgroundMethodOkosun, I. S., Turbow, S. D., McJenkin, K., Davis-Smith, Y. M., & Seale, J. P. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.07.021 · Cited by 10
Factors predicting glycaemic control in young persons with type 1 diabetes
Viklund, G., & Örtqvist, E. (2014) · European Diabetes Nursing · doi:10.1002/edn.254 · Cited by 9
Floch, J. P. L. (2010) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmsott.s7315 · Cited by 14
“73 Although this apparent observation may have been an artifact of statistical modelling, 74 a recent analysis of DCCT data suggests that HbA 1c variation adds to mean HbA 1c in predicting incidence and progression of microvascular complications.”
CD4+ CD25+ cells in type 1 diabetic patients with other autoimmune manifestations
Elaziz, D. S. A., Hafez, M., Galal, N. M., Meshaal, S. S., & Elmarsafy, A. M. (2013) · Journal of Advanced Research · doi:10.1016/j.jare.2013.09.004 · Cited by 8
Counseling and depression among diabetic patients
Mansour, E. A., Gemeay, E. M., & Moussa, I. M. (2013) · Saudi Medical Journal · doi:10.15537/1658-3175.5727 · Cited by 8
“34 (3) Depression among diabetic patient .”
Deng, Y., Liang, Y., Lin, S., Wen, L., Li, J., Zhou, Y., Shen, M., Zheng, J., Feng, K., Sun, Y., et al. (2020) · Eye and Vision · doi:10.1186/s40662-019-0170-1 · Cited by 8
Protective Effects of Transient Glucose Exposure in Adult C. elegans
Murillo, K., Samigullin, A., Humpert, P. M., Fleming, T., Özer, K., Schlotterer, A., Hammes, H., & Morcos, M. (2022) · Antioxidants · doi:10.3390/antiox11010160 · Cited by 9
“Studies examining glucose control in patients with diabetes (type 1 and type 2) suggest that some of the detrimental effects of poor glycemic control are irreversible, even when glucose is later normalized due to stricter therapy regimens [2,16].”
BackgroundMethodInfluentialCunha-Vaz, J. G. (2015) · Ophthalmic Research · doi:10.1159/000438794 · Cited by 8
Vivanco-Rojas, Ó., López-Letayf, S., Londoño-Angarita, V., Magaña‐Guerrero, F. S., Buentello‐Volante, B., & Garfias, Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12206583 · Cited by 8
“However, the impact of reducing these parameters explains only 11% of the reduction in the risk of suffering from RD globally [29].”
BackgroundSomolinos-Simón, F. J., García-Sáez, G., Tapia, J. A. R., Corcoy, R., & Hernando, M. E. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111803 · Cited by 7
Chokshi, T. J., Fickweiler, W., JANGOLLA, S. V. T., Park, K., Wu, I., Shah, H., Sun, J. K., Aiello, L. P., & King, G. L. (2024) · Diabetes Care · doi:10.2337/dc24-1260 · Cited by 8
Tseng, Y., Tsan, Y., & Chen, P. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14364 · Cited by 9
Glycated hemoglobin A1c(HbA1c) and diabetes: a new era?
Katsiki, N., Παπάνας, Ν., Mikhailidis, D. P., & Fonseca, V. A. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.618179 · Cited by 8
Buschur, E., & Lawrence, S. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-43827-6_9 · Cited by 10
Hsiao, Y., Shen, F., Weng, S., Wang, P., Chen, Y., & Lee, J. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080689 · Cited by 9
Lassé, M., Stampfli, A. R., Orban, T., Bothara, R. K., Gerrard, J. A., Fairbanks, A. J., Pattinson, N. R., & Dobson, R. C. J. (2021) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2021.130013 · Cited by 7
Jarab, A. S., Al-Qerem, W. A., Hamam, H., Heshmeh, S. A., Al-Azzam, S. I., Mukattash, T. L., & Alefishat, E. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0285142 · Cited by 9
The relationship between hemoglobin a1c and chronic complications in diabetes mellitus
Timar, B., & Albai, O. (2012) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/v10255-012-0015-3 · Cited by 8
“In our study the prevalence of retinopathy was merely twofold higher in patients treated conventionally compared to those on intensive treatment: 54% versus 34% [4, 19, 20].”
Kitaoka, K., Takenouchi, A., Tsuboi, A., Fukuo, K., & Kazumi, T. (2016) · Journal of Diabetes Research · doi:10.1155/2016/4351376 · Cited by 8
“Long-term glycemic control, as expressed by hemoglobin (Hb) A1c levels, is the main risk factor for the development of microvascular complications including diabetic kidney disease [2, 3].”
BackgroundRoth, L., Steckhan, N., & Schwarz, P. E. H. (2025) · Frontiers in Digital Health · doi:10.3389/fdgth.2025.1544668 · Cited by 10
Moheghi, A., Tadi, F. B., Mougehi, S. M. N., Mostafavinia, A., Amini, A., Tohidian, M., Bayat, S., Hosseini, R., Mohsenifar, Z., Chien, S., et al. (2026) · European Journal of Plastic Surgery · doi:10.1007/s00238-025-02384-5 · Cited by 7
“Approximately 40% of patients remain undiagnosed [ 3], and inadequate control contributes to long-term complications [4].”
Alleyn, C., Laffel, L. M., Volkening, L. K., Anderson, B. J., Nansel, T. R., Wysocki, T., & Weissberg-Benchell, J. A. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03404.x · Cited by 6
Veiby, N., Simeunovic, A., Heier, M., Brunborg, C., Saddique, N., Moe, M. C., Dahl‐Jørgensen, K., Petrovski, G., & Margeirsdottir, H. D. (2021) · Acta Ophthalmologica · doi:10.1111/aos.15018 · Cited by 6
“only explained ~12% of the total variation in the risk of DR, which means that up to 88% must have been explained by other factors (1995; Lachin et al. 2008).”
BackgroundCurrent Research Perspectives in Understanding Diabetic Retinopathy
Sripriya, S., Raman, R., Soumittra, N., & Pandian, A. J. (2017) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-4-431-56511-6_19 · Cited by 6
Chattopadhyay, S., George, A., John, J., & Sathyapalan, T. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13111 · Cited by 7
“Although the extent of postprandial glycemic excursions was speculated as a possible cause, subsequent reanalysis explained the results by the differences in mean HbA1c between treatment groups over time.(40) In our patients, PGS as a continuous variable was a stronger predictor of prognosis than 2hPPG itself.”
BackgroundAccuracy of the point-of-care glucose meter for use in calves
NISHI, Y., MURAKAMI, Y., OTSUKA, M., TSUKANO, K., AJITO, T., & SUZUKI, K. (2019) · Journal of Veterinary Medical Science · doi:10.1292/jvms.19-0272 · Cited by 5
Ünlütürk, U., Bahçecioğlu, A. B., Samadi, A., Lay, İ., Bayraktar, M., & Dağdelen, S. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02110-7 · Cited by 6
The role of mannose-binding lectin (MBL) in diabetic retinopathy: A scoping review
Dias, P. B., Messias-Reason, I., Hokazono, K., & Nisihara, R. (2024) · Immunology Letters · doi:10.1016/j.imlet.2024.106863 · Cited by 5
Al-Haddad, F. A., Musaiger, A. O., & Al-Qallaf, M. (2015) · Bahrain Medical Bulletin · doi:10.12816/0014394 · Cited by 6
Ciechanowska, A., Góra, I. M., Sabalińska, S., Foltyński, P., & Ładyżyński, P. (2021) · Journal of Applied Biomedicine · doi:10.1016/j.bbe.2021.04.010 · Cited by 8
Deravi, N., Sharifi, Y., Koohi, F., Zadeh, S. S. T., Masrouri, S., Azizi, F., & Hadaegh, F. (2023) · BMC Public Health · doi:10.1186/s12889-023-15463-8 · Cited by 6
Diabetic Retinopathy – a Common Disease
Spital, G., & Faatz, H. (2023) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/a-2108-6758 · Cited by 6
Stull, M., Strilka, R. J., Clemens, M. S., & Armen, S. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815593291 · Cited by 5
“It is an integrated measure of glycemic exposure and when elevated, is associated with vascular complications.(7) Increased GV has emerged as another glycemic control metric that may also be linked to morbidity and mortality.”
BackgroundQin, X., Xiao, Y., Cui, L., Chen, S., An, Q., Yuan, T., Wu, Y., Lin, Q., Yang, C., & Zou, H. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02291-4 · Cited by 4
Raja, S., Raja, A., Ali, A., & Asghar, M. S. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01602-y · Cited by 5
“There exists a well-established and consistent association between hyperglycemia, as indicated by HbA1c levels, and the onset and advancement of both microvascular and macrovascular complications in diabetes, especially in T2D [36–38].”
Prediction of retinopathy risk: A prospective cohort study in China
Xu, X., Wang, D., Alam, U., Qiu, S., Ding, Y., Sun, Z., & Garrib, A. V. (2025) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2025.103251 · Cited by 5
Yin, J., Han, M., Li, L., Li, Y., Liu, Z., Yang, J., & Liu, Y. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s331833 · Cited by 4
Management of Type 2 Diabetes Mellitus
Marks, J. B. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1028-7_8 · Cited by 4
Automated Adaptation of Insulin Treatment in Type 1 Diabetes
Fabris, C., Gautier, T., & Breton, M. D. (2021) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc46164.2021.9630191 · Cited by 7
“However, insulin therapies are not as efficient as the natural endogenous insulin secretion, and suboptimal insulin dosing is still common in the management of T1D, causing potentially life-threatening hypoglycemic episodes [12],[13] and/or sustained hyperglycemia which in turn leads to the development and progression…”
BackgroundSinclair, S. H., & Luttrull, J. K. (2022) · Journal of Ophthalmology Research Reviews & Reports · doi:10.47363/jorrr/2022(3)130 · Cited by 3
Role of 19 SNPs in 10 genes with type 2 diabetes in the Pakistani population
Khan, N., Paterson, A. D., Roshandel, D., Maqbool, S., Fazal, N., Ali, L., Khurram, R., Maqsood, S. I., Ali, S. H. B., Khan, H., et al. (2022) · Gene · doi:10.1016/j.gene.2022.146899 · Cited by 4
Diabetic Retinopathy and Maculopathy
Hammes, H., Lemmen, K. D., & Bertram, B. (2023) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1946-3798 · Cited by 4
Circulatory Biomarkers and Diabetic Retinopathy in Racial and Ethnic Populations
Fickweiler, W., Mitzner, M. G., Jacoba, C. M. P., & Sun, J. K. (2023) · Seminars in Ophthalmology · doi:10.1080/08820538.2023.2168488 · Cited by 5
“Thus, TNF-α in the circulation of patients with diabetes may be more reflective of systemic disease such as chronic kidney disease and not be specific to DR.Higher inflammatory IL-6 concentration has been found in vitreous and aqueous samples from patients with PDR70 and DME.60,71,72 Elevated plasma IL-6 concentration…”
BackgroundInfluentialXing, Y., Wu, M., Liu, H., Li, P., Pang, G., Zhao, H., & Wen, T. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01269-0 · Cited by 4
“Achieving HbA1c values of 7% or less is associated with a decreased risk of micro-and macrovascular complications [3, 4].”
BackgroundGulliford, M. C., Dodhia, H., Sivaprasad, S., & Ashworth, M. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010424 · Cited by 4
“[16] In type 1 diabetes, differences in HbA1c explain ‘virtually all’ of the risk of microvascular complications of diabetes.[17] Although the association between HbA1c and retinopathy is well established [18], few studies have identified organisational characteristics that may mediate this relationship.”
BackgroundThoughts on paediatric diabetes care in the UK
Krone, N. P., Högler, W., & Barrett, T. G. (2009) · The British Journal of Diabetes · doi:10.1177/1474651409350950 · Cited by 5
What are the best options for controlling prandial glycemia?
Clement, S. C. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0056-z · Cited by 4
The HEART2D trial—new questions beyond answers
Monnier, L., & Colette, C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.98 · Cited by 4
Relative Importance and Contribiton of Risk Factors for Diabetic Retinopathy and Macular Edema
Y, F. E. T. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000337 · Cited by 4
Prevalence of sensorineural hearing loss in children and adolescents with diabetes mellitus
Treviño‐González, J. L., Campuzano-Bustamante, D. I., Flores‐Caloca, Ó., Santos-Lartigue, R., & Villegas-González, M. J. (2015) · Medicina Universitaria · doi:10.1016/j.rmu.2015.06.004 · Cited by 4
Cryer, P. E. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00034-1 · Cited by 7
Avogaro, A. (2011) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2010.12.001 · Cited by 4
Genome-Wide Association Study to Identify Genetic Variants Associated With Diabetic Maculopathy
Gurung, R. L., Nangia, C., Cai, T., FitzGerald, L. M., McComish, B. J., Liu, E., Kaidonis, G., Ridge, B., Hewitt, A. W., Vote, B. J. T., et al. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.3.55 · Cited by 3
Steinkerchner, M. S., Lee, L. H., Manda, A. R., Sheng, J., Veach, L., Gangaputra, S. S., & Kim, S. J. (2025) · Ophthalmology Science · doi:10.1016/j.xops.2025.100947 · Cited by 3
INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy Study
Kim, S. J., Gangaputra, S. S., Awamlh, S. A. H. A., Choi, L., McNeer, E. A., & Sheng, J. (2025) · Ophthalmology Science · doi:10.1016/j.xops.2025.101003 · Cited by 3
“4 Consequently, new biomarkers are needed that can better risk-stratify patients with diabetes and identify those who are at greater risk of vision loss.”
Francis, H., Januszewski, A. S., O’Rourke, M. B., Huang, M. L. H., EMA, F. K., Hardikar, A. A., Joglekar, M. V., SULLIVAN, D. R., Ma, R. C. W., Galande, S., et al. (2026) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2026.109330 · Cited by 3
Successes and Disappointments with Clinical Islet Transplantation
Cravedi, P., Ruggenenti, P. L., & Remuzzi, G. (2013) · Springer eBooks · doi:10.1007/978-94-007-6884-0_23-1 · Cited by 3
Huang, J., Hua, F., Jiang, X., Zhang, X., Yang, M., Wang, L., Huang, X., & Luo, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1130470 · Cited by 3
“However, the same HbAlc level did not reflect the same risk of complications (4).”
BackgroundOlivieri, C., Salato, M., Campanella, A., Marolo, P., Parisi, G., Neri, G., Toro, M. D., Scarmozzino, A., Broglio, F., Borrelli, E., et al. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02354-6 · Cited by 3
“The most relevant risk factors for the development of DR are the duration of diabetes, a diagnosis of type 1 diabetes and poor glycemic control [15, 24–27].”
Seyithanoğlu, M., Meşen, S., Çömez, A., Meşen, A., Beyoğlu, A., Baykişi, Y., & Baylan, F. A. (2025) · PeerJ · doi:10.7717/peerj.18841 · Cited by 4
“The Epidemiology of Diabetes Interventions and Complications study revealed that only 11% of the risk for DR is attributable to HbA1c levels, indicating that 89% of the risk is associated with other diabetes-related factors ( Lachin et al., 2008 ).”
Zheng, Z., Liu, N., Zhang, Y., Gu, X., Li, H., & Yu, X. (2025) · Translational Vision Science & Technology · doi:10.1167/tvst.14.7.27 · Cited by 4
“3 Similarly, we found a relatively weak discriminative ability of DR with the individual parameter of HbA1c compared with CP-related indices.”
Glycemic Variability and the Role It Should Play in Diabetes Management and Blood Glucose Monitoring
Bode, B. W., & Diabetes Specialist, A. D. A. (2008) · US Endocrinology · doi:10.17925/use.2008.04.2.67 · Cited by 4
Glycemic Variability in Type 1 Diabetes—Does It Matter?
Schwartz, F., & Marling, C. R. (2014) · US Endocrinology · doi:10.17925/use.2014.10.01.20 · Cited by 3
Moreno-Fernández, J., Beato-Víbora, P. I., Olvera, P., García-Seco, J. A., Gallego-Gamero, F., Herrera, M. T., & Muñoz‐Rodríguez, J. R. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109093 · Cited by 3
Glycemic Variability and Diabetes Mellitus
Jang, H. N., & Jung, H. S. (2022) · Journal of Korean Diabetes · doi:10.4093/jkd.2022.23.1.12 · Cited by 3
Extracellular Vesicles and Diabetic Retinopathy: Nano-Sized Vesicles with Mega-Sized Hopes
Habib, S., Mansour, A., Baban, B., & Elmasry, K. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1005791 · Cited by 5
Ganji, M., Fathi, A. E., Fabris, C., Lv, D., Kovatchev, B. P., & Breton, M. D. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.109714 · Cited by 3
“Careful management of diabetes is necessary to prevent complications, including kidney disease, heart disease, microvascular damage and neuropathy[5], [6], [7].”
BackgroundYakob, T., Abraham, A., Yakob, B., & Jaldo, M. M. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-090916 · Cited by 7
Curto, A., Gómez‐Polo, C., Curto, D., Muñoz-Bruguier, M., Lorenzo-Luengo, M. C., & Montero, J. (2025) · BMC Oral Health · doi:10.1186/s12903-025-05541-1 · Cited by 5
“The determination of HbA1c reflects the mean glucose levels over the past 3–4 months and is currently considered the only objective measure of long-term glycemic control [6].”
Nwanyanwu, K. H., Andoh, J. E., Chen, E. M., Xu, Y., Granados, A., Deng, Y., Desai, M. M., & Nuñez-Smith, M. (2025) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2025.06.028 · Cited by 4
Ganji, M., Koravi, L. K. C., Breton, M. D., & Fabris, C. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251359641 · Cited by 3
Evaluating the Risk Factors of Development and Progression of Diabetic Retinopathy: A Review Study
Rasoulinejad, S. A. (2022) · Shiraz E-Medical Journal · doi:10.5812/semj.117171 · Cited by 6
“found that for every 1% increase in HbA1c, the risk of DR increases by 22%, although the elevated HbA1c reflects weakly controlled diabetes correlated with DR development (11).”
BackgroundAutomation of the Consensus Guidelines in Diabetes Care: Potential Impact on Clinical Inertia
Albisser, A. M., & Inhaber, F. R. (2010) · Endocrine Practice · doi:10.4158/ep10124.or · Cited by 4
Ks, I. (2018) · INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY · doi:10.24293/ijcpml.v23i2.1145 · Cited by 5
Metadata
- Authors
- Lachin, J. M., Genuth, S., Nathan, D. M., Zinman, B., Rutledge, B. N., & for the DCCT/EDIC Research Group
- Affiliations
- George Washington University (US)
- Case Western Reserve University (US)
- Harvard University (US)
- Mount Sinai Hospital (CA)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-04-01
- Volume
- 57
- Issue
- 4
- Pages
- 995-1001
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W1992103610
- Cited by
- 555
- References
- 13
- Citations by year
- 2026: 21 · 2025: 41 · 2024: 31 · 2023: 31 · 2022: 34 · 2021: 28 · 2020: 31 · 2019: 26 · 2018: 31 · 2017: 31 · 2016: 30 · 2015: 31 · 2014: 36 · 2013: 36 · 2012: 25
- FWCI
- 22.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute
- National Eye Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
- NIH Clinical Center
- Division of Diabetes, Endocrinology, and Metabolic Diseases
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- glycemic exposure, glycemic variability, postprandial hyperglycemia, microvascular complications, diabetic retinopathy progression, HbA1c, tight glycemic control, Diabetes Control and Complications Trial
- MeSH terms
- Adolescent, Adult, Diabetes Mellitus, Type 1, Diabetic Retinopathy, Female, Glycated Hemoglobin, Humans, Insulin, Male, Reproducibility of Results, Models, Statistical, Cohort Studies, Biomarkers, Disease Progression, Patient Selection, Racial Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.